UNSPSC 51111747: Ixabepilone

This classification denotes an epothilone b analogue with the molecular formula C27H42N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K27005NP0A, chemically known as 17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1s,3s,7s,10r,11s,12s,16r)- but generally known as ixabepilone, which bears US NIH Compound Identifier 6445540.

UNSPSC 51111747 Ixabepilone is a Commodity code that encompasses pharmaceutical products, though the recent state and local opportunities tagged under it do not reflect ixabepilone procurement itself. The code shows minimal relevant recent activity specific to its nominal scope; the two opportunities posted in the source are tagged to this code but involve unrelated pharmaceutical products — one a completed Illinois Department of Public Health warehouse order for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) through a MMCAP cooperative purchasing vehicle, and the other a Seminole County, Florida IFB for naloxone and drug deactivation systems. State and local health departments and counties appear as the issuing bodies, but the mismatch between the code's intended scope and the actual procurement activity suggests either coding error or a secondary tagging pattern in the source jurisdiction's system.

Geographic activity centers on Illinois and Florida based on the recent postings. The Illinois Department of Public Health completed a $2,999,999.11 award to Chartwell Rx LLC over 12 months plus renewal options through an IFB process, while Seminole County, Florida issued an IFB (due July 26, 2023) for annual quantities of naloxone and deactivation systems with quarterly deliveries required to a specific county health facility. Neither opportunity directly reflects ixabepilone procurement, and the code's apparent misapplication in these records suggests limited actionable activity for vendors specializing in this specific pharmaceutical product at present.